FCs modulate several pathways inducing cancer cell death by inhibiting signal transducer and activator of transcription 3 (STAT3), nuclear factor-κB (NF-κB), phosphatidylinositol-3-kinase and AKT protein expression (Figure 4). Here, STAT3 is linked to cancer.